Company Filing History:
Years Active: 2023
Title: Weng-Shiang Chen: Innovator in Cancer Treatment
Introduction
Weng-Shiang Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative approaches. His work focuses on combining traditional therapies with advanced vaccine strategies to enhance treatment efficacy.
Latest Patents
Weng-Shiang Chen holds a patent for a groundbreaking method titled "Combination therapy for malignant diseases." This patent presents a new approach for treating malignant diseases by administering a traditional anti-cancer therapy alongside a DNA or protein vaccine that includes CTLA-4 and PD-1, or CTLA-4 and PD-L1. This innovative method aims to improve patient outcomes in cancer therapy.
Career Highlights
Weng-Shiang Chen is affiliated with Taipei Veterans General Hospital, where he conducts research and develops new treatment methodologies. His dedication to advancing cancer treatment has positioned him as a key figure in the medical community.
Collaborations
Weng-Shiang Chen collaborates with esteemed colleagues, including Keng-Li Lan and Yi-Sheng Shih. These partnerships enhance the research and development of innovative cancer therapies.
Conclusion
Weng-Shiang Chen's contributions to cancer treatment through his patent and collaborative efforts highlight his commitment to improving patient care. His innovative approaches are paving the way for more effective therapies in the fight against malignant diseases.